Phase 2 Erythropoietic Protoporphyria (EPP) Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Completed
Phase 2
A Phase 2, Randomized, Open Label Study of Bitopertin administered orally to Evaluate the Safety, Tolerability, Efficacy, and Protoporphyrin IX (PPIX) Concentrations in Participants with Erythropoietic Protoporphyria (EPP)
Erythropoietic Protoporphyria (EPP)
Disc Medicine, Inc.22 enrolled2 locationsACTRN12622000799752
Terminated
Phase 2
Phase II Study of CUV1647 in Erythropoietic Protoporphyria (EPP)
Erythropoietic Protoporphyria (EPP)
Clinuvel Pharmaceuticals10 enrolled1 locationACTRN12606000535572